GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Insider Ownership

Biolife Sciences (Biolife Sciences) Insider Ownership : 42.24 % (As of Jun. 03, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biolife Sciences's insider ownership is 42.24%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biolife Sciences's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biolife Sciences's Float Percentage Of Total Shares Outstanding is 0.00%.


Biolife Sciences Insider Ownership Historical Data

The historical data trend for Biolife Sciences's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Insider Ownership Chart

Biolife Sciences Historical Data

The historical data trend for Biolife Sciences can be seen below:

2009-05-31 2009-06-30 2009-07-31 2009-08-31 2009-09-30 2009-10-31 2009-11-30 2009-12-31 2010-01-31 2010-02-28
Insider Ownership 42.24 42.24 42.24 42.24 42.24 42.24 42.24 42.24 42.24 42.24

Biolife Sciences Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020